Tetiana Aleksandrova, founder and CEO of Subsense Inc., argues that the current focus on invasive surgical brain-computer interfaces (BCIs) embeds ethical issues from the outset. She contends that the field's assumption of a trade-off between invasiveness and performance, and between risk and performance, limits the ethical debate to whether benefits justify harm to a few. Aleksandrova advocates for reversible, non-permanent interfaces, stating that true autonomy and revocable consent are built into the hardware design rather than being mere policy add-ons. AI
IMPACT Reversible BCI designs could offer greater user autonomy and ethical flexibility than permanent implants.
RANK_REASON Opinion piece by an industry executive discussing the ethical implications of BCI design choices.
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
